We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > JW Pharmaceutical

News List

JW Pharmaceutical gains Korean approval for Hemlibra firstwordpharma
January 21, 2019
JW Pharmaceutical said Sunday that it gained the South Korean drug regulator's approval to begin domestic sales of the hemophilia treatment Hemlibra, developed by Roche's Chugai unit, reported The Korea Herald.
JW Pharmaceutical gains Korean approval for Hemlibra firstwordpharma
January 21, 2019
JW Pharmaceutical said Sunday that it gained the South Korean drug regulator's approval to begin domestic sales of the hemophilia treatment Hemlibra, developed by Roche's Chugai unit, reported The Korea Herald.
JW Pharmaceutical invests in British anti-cancer drugs developer pharmaceutical-technology
October 30, 2018
South Korea-based pharmaceutical products company JW Pharmaceutical has invested $2.6m in British anti-cancer drugs developer Argonaut Therapeutics.